ADVANCED LUNG CANCER
Clinical trials for ADVANCED LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer immunotherapy trial pulled before it began
Disease control TerminatedThis study was designed to test two immunotherapy drugs, atezolizumab and tiragolumab, in people with advanced lung cancer that has special immune cell clusters called tertiary lymphoid structures. The trial was withdrawn before enrolling any participants, so no results are avail…
Matched conditions: ADVANCED LUNG CANCER
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New adaptive palliative care model aims to give right care at the right time
Symptom relief ENROLLING_BY_INVITATIONThis study tests a home-based palliative care program called TIER-PC that adjusts the care team based on a patient's symptoms and ability to function. It includes 60 adults with advanced heart failure or certain cancers living in Manhattan. The program adds more specialists—like …
Matched conditions: ADVANCED LUNG CANCER
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 26, 2026 13:42 UTC